BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32515520)

  • 1. LncRNA-XIST promotes the oxidative stress-induced migration, invasion, and epithelial-to-mesenchymal transition of osteosarcoma cancer cells through miR-153-SNAI1 axis.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cell Biol Int; 2020 Oct; 44(10):1991-2001. PubMed ID: 32515520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
    Zhang R; Xia T
    Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma.
    Zhang Z; Zhang M; Chen Q; Zhang Q
    Cancer Gene Ther; 2017 Feb; 24(2):83-88. PubMed ID: 28186090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
    Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
    Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
    Ye F; Tian L; Zhou Q; Feng D
    Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA XIST Promotes Osteosarcoma Progression by Targeting Ras-Related Protein RAP2B via miR-320b.
    Lv GY; Miao J; Zhang XL
    Oncol Res; 2018 Jul; 26(6):837-846. PubMed ID: 28409547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
    Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y; Zhao F; Zhang Z; Sun F; Wang M
    Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.
    Shi Y; Huang J; Zhou J; Liu Y; Fu X; Li Y; Yin G; Wen J
    Oncol Rep; 2015 Jul; 34(1):399-406. PubMed ID: 25998694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1.
    Zhao X; Xu Y; Sun X; Ma Y; Zhang Y; Wang Y; Guan H; Jia Z; Li Y; Wang Y
    J Cell Biochem; 2019 Apr; 120(4):5495-5504. PubMed ID: 30302813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-determining region Y-box protein 3 induces epithelial-mesenchymal transition in osteosarcoma cells via transcriptional activation of Snail1.
    Qiu M; Chen D; Shen C; Shen J; Zhao H; He Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):46. PubMed ID: 28335789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA XIST regulates the EGF receptor to promote TGF-β1-induced epithelial-mesenchymal transition in pancreatic cancer.
    Zou L; Chen FR; Xia RP; Wang HW; Xie ZR; Xu Y; Yu JH; Wang KH
    Biochem Cell Biol; 2020 Apr; 98(2):267-276. PubMed ID: 31013436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA XIST Regulates miR-137-EZH2 Axis to Promote Tumor Metastasis in Colorectal Cancer.
    Liu X; Cui L; Hua D
    Oncol Res; 2018 Dec; 27(1):99-106. PubMed ID: 29495975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail.
    Wang Z; Chen X; Zhao Y; Jin Y; Zheng J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):87-96. PubMed ID: 30341688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.